The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research
Open accessPublished version of a preprint
The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index; 38 of the 52 sources its claims cite were checked for support.
Abstract
Reproducible science requires transparent reporting. The ARRIVE guidelines (Animal Research: Reporting of In Vivo Experiments) were originally developed in 2010 to improve the reporting of animal research. They consist of a checklist of information to include in publications describing in vivo experiments to enable others to scrutinise the work adequately, evaluate its methodological rigour, and reproduce the methods and results. Despite considerable levels of endorsement by funders and journals over the years, adherence to the guidelines has been inconsistent, and the anticipated improvements in the quality of reporting in animal research publications have not been achieved. Here, we introduce ARRIVE 2.0. The guidelines have been updated and information reorganised to facilitate their use in practice. We used a Delphi exercise to prioritise and divide the items of the guidelines into 2 sets, the "ARRIVE Essential 10," which constitutes the minimum requirement, and the "Recommended Set," which describes the research context. This division facilitates improved reporting of animal research by supporting a stepwise approach to implementation. This helps journal editors and reviewers verify that the most important items are being reported in manuscripts. We have also developed the accompanying Explanation and Elaboration (E&E) document, which serves (1) to explain the rationale behind each item in the guidelines, (2) to clarify key concepts, and (3) to provide illustrative examples. We aim, through these changes, to help ensure that researchers, reviewers, and journal editors are better equipped to improve the rigour and transparency of the scientific process and thus reproducibility.
Overview
CoChat Summary
TL;DR
ARRIVE 2.0 updates the 2010 ARRIVE reporting guidelines for in vivo animal research, reorganising 21 items into the “ARRIVE Essential 10” minimum set and a “Recommended Set” for research context. The revision used a Delphi exercise and an accompanying Explanation and Elaboration document to improve transparency, methodological scrutiny, and reproducibility.
Key findings
- Despite endorsement by more than a thousand journals, adherence to the original ARRIVE guidelines has been inconsistent: randomisation was reported in only 30%–40% of publications, blinding in approximately 20%, sample size justification in less than 10%, and all basic animal characteristics in less than 10%.
- ARRIVE 2.0 divides items into two prioritised groups with no ranking within each group: the “ARRIVE Essential 10” as the minimum requirement and the “Recommended Set” to describe research context; together they comprise items 1–21.
- New additions include inclusion and exclusion criteria, protocol registration, and data access in line with the FAIR Data Principles; the accompanying Explanation and Elaboration document explains each item’s rationale, clarifies key concepts, and provides illustrative examples.
- A Delphi exercise with experts from 19 countries ranked items by relative importance for assessing reliability of research findings, and the revised guidelines were road tested with researchers preparing manuscripts describing in vivo studies.
Methods
- Guideline revision by an international working group with expertise across life sciences, including funders, journal editors, statisticians, methodologists, and academic/industry researchers.
- A Delphi exercise with external stakeholders from 19 countries provided feedback, suggested new items, and ranked items by importance; demographics and full methods/results are in Supporting Information S1 Delphi and S1 Data.
- Following BioRxiv publication, the revised guidelines and E&E were road tested with researchers preparing in vivo manuscripts; this study is presented in Supporting Information S1 Road Testing and S2 Data.
Limitations
- The paper states two main factors limit the impact of ARRIVE: the extent to which editorial and journal staff actively enforce reporting standards, and insufficient awareness among researchers and organisations of the consequences of incomplete reporting; it cites a PLOS ONE randomised controlled trial where requesting a completed ARRIVE checklist alone failed to improve disclosure.
- The paper also states that the level of resource required from journals and editors likely prohibits implementation of all ARRIVE items.
- The paper does not present a formal limitations section for ARRIVE 2.0 itself; evident from the text, the main article reports no empirical evaluation of ARRIVE 2.0’s effect on reporting quality, and road-testing details are placed in Supporting Information rather than the main text.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Valid · 3 Not valid · 2 Not checked · 20 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“animal characteristics (all basic characteristics reported in less than 10% of publications)”
§ The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research > Why good reporting is important
What the sources say
- Could not verifycites [11] MR Macleod, 2015, Risk of bias in reports of in vivo research: a focus for improvement, PLoS Biol sourceExperimental — accuracy not yet measured
The paper’s Abstract (page unavailable) reports how often publications described randomisation, blinded outcome assessment, sample-size calculations and conflicts of interest. Searches for animal characteristics, including species, strain, sex, age and weight, found no passage giving a figure for publications reporting all basic characteristics. The less-than-10% claim therefore cannot be verified from our copy. (LLM, conf=0.72)
- Partly supportedcites [31] MT Avey, 2016, The Devil Is in the Details: Incomplete Reporting in Preclinical Animal Research., PLoS ONE. sourceExperimental — accuracy not yet measured
The Results report poor reporting of animal-related details among 47 preclinical studies, and the Discussion says basic information such as sex and age was routinely omitted. But the Results’ 9% figure refers to allocating animals to experimental groups and to housing and husbandry—not to the proportion of publications reporting all basic animal characteristics. The claimed less-than-10% figure for all characteristics is therefore not established by our copy. (LLM, conf=0.83)
- Disputedcites [32] V Leung, 2018, ARRIVE has not ARRIVEd: Support for the ARRIVE (Animal Research: Reporting of in vivo Experiments) guidelines does not improve the reporting quality of papers in animal welfare, analgesia or anesthesia., PLoS ONE. sourceExperimental — accuracy not yet measured
Table 3 (Results > Items; page unavailable) reports that all experimental-animal characteristics were fully reported in 15.4% and 29.5% of papers in ARRIVE-supporting journals in 2009 and 2015, respectively, and 10.9% of papers in non-supporting journals in 2015. These figures exceed the claimed threshold of less than 10%. (LLM, conf=0.92)
Checked by a reasoning model — may be wrong.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“randomisation (reported in only 30%–40% of publications)”
§ The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research > Why good reporting is important
What the sources say
- Partly supportedcites [11] MR Macleod, 2015, Risk of bias in reports of in vivo research: a focus for improvement, PLoS Biol sourceExperimental — accuracy not yet measured
The paper reports randomisation in 35.7% of CAMARADES publications from 2009–2010, which falls within the claimed range. But the Abstract also reports lower overall rates in its datasets (20%, 24.8%, and 14.4%), so 30%–40% is not supported as an unqualified rate for publications generally. (LLM, conf=0.88)
- Disputedcites [31] MT Avey, 2016, The Devil Is in the Details: Incomplete Reporting in Preclinical Animal Research., PLoS ONE. sourceExperimental — accuracy not yet measured
The Results report randomization as a composite item in 23% of the 47 studies, not 30%–40%. They separately report that 47% used the term “randomization”; neither measure falls within the claimed range. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
- Disputedcites [32] V Leung, 2018, ARRIVE has not ARRIVEd: Support for the ARRIVE (Animal Research: Reporting of in vivo Experiments) guidelines does not improve the reporting quality of papers in animal welfare, analgesia or anesthesia., PLoS ONE. sourceExperimental — accuracy not yet measured
The Results (Sub-items; page unavailable) state that randomization (sub-item 6b) was reported in more than 50% of the papers studied, contrary to the claimed 30%–40%. The Discussion’s lower 13%–20% figure concerns reporting the allocation method, not reporting randomization itself. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“However, despite this level of support, recent studies have shown that important information as set out in the ARRIVE guidelines is still missing from most publications sampled.”
§ The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research > Why good reporting is important
What the sources say
- Supportedcites [11] MR Macleod, 2015, Risk of bias in reports of in vivo research: a focus for improvement, PLoS Biol source
The indexed Abstract reports that 797 of 1,168 sampled publications (68%) did not report any of four important risk-of-bias measures. It also notes that reporting remained low even after journals endorsed the ARRIVE guidelines. No page number is supplied in our copy. (LLM, conf=0.90)
- Supportedcites [31] MT Avey, 2016, The Devil Is in the Details: Incomplete Reporting in Preclinical Animal Research., PLoS ONE. source
The Results (page not provided) report that papers published after ARRIVE was introduced still reported fewer than 50% of the assessed reporting items. The Discussion (page not provided) concludes that reporting was generally incomplete, including for details important to assessing study validity. The finding concerns the paper’s sample of preclinical animal studies. (LLM, conf=0.91)
- Supportedcites [32] V Leung, 2018, ARRIVE has not ARRIVEd: Support for the ARRIVE (Animal Research: Reporting of in vivo Experiments) guidelines does not improve the reporting quality of papers in animal welfare, analgesia or anesthesia., PLoS ONE. source
The Discussion, under “Adherence to reporting guidelines remains low despite journal support,” says reporting standards in the sampled papers were low and that reporting of important study-design indicators—randomization, blinding, sample-size calculation, and data handling—remained low. This supports the claim that important ARRIVE information was missing from most sampled publications. (LLM, conf=0.92)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The ARRIVE guidelines (Animal Research: Reporting of In Vivo Experiments) were originally developed in 2010 to improve the reporting of animal research.”
- Also stated in: § Why good reporting is important · plain
“In an attempt to improve the reporting of animal research, the Animal Research: Reporting of In Vivo Experiments (ARRIVE) guidelines were published in 2010.”
§ The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research > Abstract
What the sources say
- Not checked — no full text of the sourcecites [21] C Kilkenny, 2010, Improving bioscience research reporting: ARRIVE-ing at a solution, Lab Anim source
- Not checked — no full text of the sourcecites [22] C Kilkenny, 2010, Animal research: reporting in vivo experiments: the ARRIVE guidelines, J Gene Med source
- Supportedcites [23] C Kilkenny, 2010, Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research, PLoS Biol source
In “Improving the Reporting of Animal Experiments—The ARRIVE Guidelines,” the authors say they led the initiative to produce ARRIVE guidelines for reporting animal research. “Improved Reporting Will Maximise the Output of Published Research” states that the guidelines were developed to improve the information provided in publications. This 2010 paper presents the guidelines, although it notes that drafting began at a June 2009 meeting. (LLM, conf=0.91)
- Supportedcites [24] C Kilkenny, 2010, Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research., Journal of Pharmacology & Pharmacotherapeutics. source
In “Improving the reporting of animal experiments—the ARRIVE guidelines,” the authors say they developed ARRIVE as guidelines for reporting animal research. The paper describes a draft agreed in 2009, while its References list the ARRIVE guidelines’ publications in 2010; thus 2010 is supported as the year the original guidelines appeared, not the year work on them began. (LLM, conf=0.90)
- Not checked — no full text of the sourcecites [25] C Kilkenny, 2010, Animal Research: Reporting In Vivo Experiments: the ARRIVE guidelines, J Physiol source
- Supportedcites [26] C Kilkenny, 2010, Animal Research: Reporting In Vivo Experiments: the ARRIVE guidelines, Exp Physiol source
The Funding section identifies this text as the ARRIVE guidelines and says they are excerpted from a 2010 publication titled “Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research.” The publication details in the ITEM RECOMMENDATION section place this version in Experimental Physiology in 2010 (pp. 842–844). (LLM, conf=0.92)
- Supportedcites [27] JC McGrath, 2010, Guidelines for reporting experiments involving animals: the ARRIVE guidelines, Br J Pharmacol source
The Background describes ARRIVE as a newly generated set of guidelines filling a gap in reporting animal studies. The Abstract calls them a new set of guidelines for reporting research involving animals, and the 2010 references establish the date. (LLM, conf=0.92)
- Not checked — no full text of the sourcecites [28] C Kilkenny, 2011, Animal Research: Reporting In Vivo Experiments-the ARRIVE Guidelines, J Cereb Blood Flow Metab source
- Not checked — no full text of the sourcecites [29] C Kilkenny, 2012, Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research, Vet Clin Pathol source
- Partly supportedcites [30] C Kilkenny, 2012, Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research, Osteoarthritis Cartilage sourceExperimental — accuracy not yet measured
The section on improving the reporting of animal experiments says ARRIVE was developed to improve reporting and describes a draft agreed at a working-group meeting in June 2009. The References list ARRIVE guideline publications from 2010, but the paper does not establish that the guidelines were originally developed in 2010 rather than first drafted in 2009. (LLM, conf=0.86)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Why good reporting is important · plain
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“blinding (reported in only approximately 20% of publications)”
§ The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research > Why good reporting is important
What the sources say
- Supportedcites [11] MR Macleod, 2015, Risk of bias in reports of in vivo research: a focus for improvement, PLoS Biol source
The passage reporting results for in vivo research from five leading UK institutions states that 201 of 1,165 publications (17.3%) reported blinding, reasonably described as approximately 20%. The paper also reports different rates in other samples, so this figure applies to that cohort rather than all publications. (LLM, conf=0.90)
- Partly supportedcites [31] MT Avey, 2016, The Devil Is in the Details: Incomplete Reporting in Preclinical Animal Research., PLoS ONE. sourceExperimental — accuracy not yet measured
The Results (page not available) identify blinding as a core reporting item and say that none of the core items were reported more than 40% of the time in the 47 studies assessed. Our copy does not give an approximately 20% figure for blinding, and the sample was limited to preclinical studies of acute lung injury treated with mesenchymal stem cells, not publications generally. (LLM, conf=0.78)
- Partly supportedcites [32] V Leung, 2018, ARRIVE has not ARRIVEd: Support for the ARRIVE (Animal Research: Reporting of in vivo Experiments) guidelines does not improve the reporting quality of papers in animal welfare, analgesia or anesthesia., PLoS ONE. sourceExperimental — accuracy not yet measured
The Results (Sub-items; page unavailable) identify blinding as a poorly reported sub-item, and the Discussion says its reporting remained low. Our copy does not give a blinding-specific figure of approximately 20%, so the numerical part of the claim is not verified. (LLM, conf=0.83)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
11 more claims · 6 with their cited sources checked
Create a free account to see all 40 claims and to verify the 3 references still open.
- Probably not a substantial claim. 20
- It may state two separate claims as one. 9
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although there have been debates on sample size calculation and power analysis [3,4,6], the need for an appropriate sample size calculation has become a major trend in research [1,2,7-11].”
From Sample size determination and power analysis using the G*Power software (2021) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The reporting frameworks that have proven durable in other domains, such as CONSORT for randomized trials,40 MIAME for microarray experiments,41 and ARRIVE for animal research,42 emerged from sustained, community-based development, and turned informal good practice into structured requirements only once the underlying science had matured enough to support them.”
From Designing reproducible large-language-model-assisted scientific analyses (2026) · cites this paper as [42]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Some of the highly adopted checklists include CONSORT (Consolidated Standards of Reporting Trials) [19,20], ARRIVE (Animal Research: Reporting of In Vivo Experiments) [13,14], and PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) [21].”
From Open Science 2.0: Towards a truly collaborative research ecosystem (2023) · cites this paper as [14]
The cited source says what the claim attributes to it.
In the citing paper
“To ensure that the recommendations are as clear and useful as possible to the target audience, this document was road tested alongside the revised guidelines with researchers preparing manuscripts describing in vivo research [13].”
From Reporting animal research: Explanation and elaboration for the ARRIVE guidelines 2.0 (2020) · cites this paper as [13]
In the citing paper
“All experiments were designed and reported according to the Animal Research: Reporting of In Vivo Experiments guidelines (Percie du Sert et al., 2020).”
From Complex bioactive nanofibrous dura mater repairs traumatic brain injury (2026) · cites this paper as Percie du Sert et al., 2020
Citations
Cites
The FAIR Guiding Principles for scientific data management and stewardship
Wilkinson, M. D., Dumontier, M., Aalbersberg, I. J., Appleton, G., Axton, M., Baak, A., Blomberg, N., Boiten, J.-W., da Silva Santos, L. B., Bourne, P. E., et al. (2016) · Scientific Data · doi:10.1038/sdata.2016.18 · Cited by 18,423
Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research
Kilkenny, C., Browne, W. J., Cuthill, I. C., Emerson, M., & Altman, D. G. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000412 · Cited by 7,300
Self-citationImproving bioscience research reporting: The ARRIVE guidelines for reporting animal research
Kilkenny, C., Browne, W. J., Cuthill, I. C., Emerson, M., & Altman, D. G. (2010) · Journal of Pharmacology and Pharmacotherapeutics · doi:10.4103/0976-500x.72351 · Cited by 6,277
Self-citationAnimal research: Reporting in vivo experiments: The ARRIVE guidelines
Kilkenny, C., Browne, W., Cuthill, I. C., Emerson, M., & Altman, D. G. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00872.x · Cited by 3,625
Self-citationRaise standards for preclinical cancer research
Begley, C. G., & Ellis, L. M. (2012) · Nature · doi:10.1038/483531a · Cited by 2,979
Reporting animal research: Explanation and elaboration for the ARRIVE guidelines 2.0
Percie du Sert, N., Ahluwalia, A., Alam, S., Avey, M. T., Baker, M., Browne, W. J., Clark, A., Cuthill, I. C., Dirnagl, U., Emerson, M., et al. (2020) · PLOS Biology · doi:10.1371/journal.pbio.3000411 · Cited by 2,677
Self-citationAnimal Research: Reporting in vivo Experiments—The ARRIVE Guidelines
Kilkenny, C., Browne, W., Cuthill, I. C., Emerson, M., & Altman, D. G. (2011) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2010.220 · Cited by 2,012
Self-citationThe preregistration revolution
Nosek, B. A., Ebersole, C. R., DeHaven, A. C., & Mellor, D. T. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1708274114 · Cited by 1,998
Guidelines for reporting experiments involving animals: the ARRIVE guidelines
McGrath, J., Drummond, G., McLachlan, E., Kilkenny, C., & Wainwright, C. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00873.x · Cited by 1,592
Guidance for Developers of Health Research Reporting Guidelines
Moher, D., Schulz, K. F., Simera, I., & Altman, D. G. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000217 · Cited by 1,437
Cited by
Items 1,601–1,700 of 6,206
P7C3-A20 treats traumatic brain injury in rats by inhibiting excessive autophagy and apoptosis
Yang, Z., Wang, Z., Deng, X., Zhu, L., Song, Z., Cao, C., & Li, X. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.380910 · Cited by 11
Schäufele, T. J., Kolbinger, A., Friedel, J., Gurke, R., Geißlinger, G., Weigert, A., Pierre, S. C., & Scholich, K. (2023) · British Journal of Pharmacology · doi:10.1111/bph.16261 · Cited by 12
Anti-Nogo-A Antibody Therapy Improves Functional Outcome Following Traumatic Brain Injury
Powers, B. E., Ton, S. T., Farrer, R. G., Chaudhary, S., Nockels, R. P., Kartje, G. L., & Tsai, S. (2023) · Neurorehabilitation and neural repair · doi:10.1177/15459683231203194 · Cited by 12
Miyake, T., Mochizuki, T., Nakagawa, T., Nakamura, M., Emoto, C., Komiyama, N., Hirabayashi, M., Tsuruta, S., Shimojo, T., Terao, K., et al. (2023) · British Journal of Pharmacology · doi:10.1111/bph.16270 · Cited by 11
Taylor, K. W., Howdeshell, K. L., Bommarito, P. A., Sibrizzi, C. A., Blain, R. B., Magnuson, K., Lemeris, C., Tracy, W., Baird, D. D., Jackson, C. L., et al. (2023) · Environment International · doi:10.1016/j.envint.2023.108307 · Cited by 14
Hydroxytyrosol Induces Dyslipidemia in an ApoB100 Humanized Mouse Model
Hazas, M. L. D. L., del Saz‐Lara, A., Cedó, L., Crespo, M. C., Tomé‐Carneiro, J., Chapado, L. A., Macià, A., Visioli, F., Escolá‐Gil, J. C., & Dávalos, A. (2023) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202300508 · Cited by 11
Neutralization of extracellular histones by sodium-Β-O-methyl cellobioside sulfate in septic shock
Garcia, B., Su, F., Dewachter, L., Wang, Y., Li, N., Remmelink, M., Eycken, M. V., Khaldi, A., Favory, R., Herpain, A., et al. (2023) · Critical Care · doi:10.1186/s13054-023-04741-x · Cited by 11
Maiarù, M., Leese, C., Silva-Hucha, S., Fontana-Giusti, S., Tait, L., Tamagnini, F., Davletov, B. A., & Hunt, S. P. (2024) · Journal of Pain · doi:10.1016/j.jpain.2024.01.331 · Cited by 11
Wajima, C. S., Pitol‐Palin, L., Batista, F. R. D. S., dos Santos, P. H., Matsushita, D. H., & Okamoto, R. (2024) · Scientific Reports · doi:10.1038/s41598-024-53260-4 · Cited by 14
A comparative study of human and porcine-derived decellularised nerve matrices.
Li, R., Qiu, S., Yang, W., Rao, Z., Chen, J., Yang, Y., Zhu, Q., Liu, X., Bai, Y., & Quan, D. (2023) · PubMed Central · doi:10.12336/biomatertransl.2023.03.006 · Cited by 16
Zhao, Y., Lan, Y., Liu, L., Hao, J., Wang, H., & Ji, L. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1348884 · Cited by 14
Teichmann, T., Pflüger‐Müller, B., Giménez, V. M. M., Sailer, F. K., Dirks, H., Zehr, S., Warwick, T., Brettner, F. E. B., Munoz‐Tello, P., Zimmer, A., et al. (2024) · British Journal of Pharmacology · doi:10.1111/bph.17366 · Cited by 11
Moein, H.-R., Sendra, V. G., Jamali, A., Kheirkhah, A., Harris, D. L., & Hamrah, P. (2021) · Scientific Reports · doi:10.1038/s41598-021-83412-9 · Cited by 11
Ding, H., Cui, S., Cui, X., Liu, Y., Hu, X., Zhao, H., Qin, Y., Kurban, N., & Zhang, Y. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15511 · Cited by 11
Benítez, R., Caro, M., Andrés‐León, E., O’Valle, F., & Delgado, M. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15752 · Cited by 11
Huang, T., Fu, X., Wang, N., Yang, M., Zhang, M., Wang, B., Chen, T., Majaz, S., Wang, H., Wong, C., et al. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15614 · Cited by 14
Menz, J., Hundt, L., Schulze, T., Schmoeckel, K., Menges, P., & Domańska, G. (2021) · Scientific Reports · doi:10.1038/s41598-021-95592-5 · Cited by 11
Optimization of SPIO Injection for Sentinel Lymph Node Dissection in a Rat Model
Peek, M. C. L., Saeki, K., Ohashi, K., Chikaki, S., Baker, R., Nakagawa, T., Kusakabe, M., Douek, M., & Sekino, M. (2021) · Cancers · doi:10.3390/cancers13195031 · Cited by 11
Goon, D. E., Rahim, S. A., Sakri, A. H. M., Mazlan, M., Tan, J. K., Aziz, M. A., Noor, N. M., Ibrahim, E., & Kadir, S. H. S. A. (2021) · Scientific Reports · doi:10.1038/s41598-021-00454-9 · Cited by 13
Walker, L. C., Campbell, E. J., Huckstep, K. L., Chen, N. A., Langmead, C. J., & Lawrence, A. J. (2021) · Pharmacology Research & Perspectives · doi:10.1002/prp2.907 · Cited by 11
Souza‐Monteiro, D., Guerra, M. C. D. S., Bittencourt, L. O., Aragão, W. A. B., Dionizio, A. S., Silveira, F. M., Buzalaf, M. A. R., Martins, M. D., Lopez, M. E. C., & Lima, R. R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042251 · Cited by 13
Exceptional longevity in northern peripheral populations of Wels catfish (Silurus glanis)
Bergström, K., Nordahl, O., Söderling, P., Koch‐Schmidt, P., Borger, T., Tibblin, P., & Larsson, P. (2022) · Scientific Reports · doi:10.1038/s41598-022-12165-w · Cited by 11
Monteiro, M., Menezes-Pinto, D., Ferreira‐Duarte, M., Dias‐Pereira, P., Morato, M., & Duarte‐Araújo, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113233 · Cited by 13
Duan, J., Yuan, W., Jiang, J., Wang, J., Yan, X., Liu, F., & Liu, A. (2023) · Molecular Medicine Reports · doi:10.3892/mmr.2023.12934 · Cited by 11
Zhang, Y., Steinmetz‐Späh, J., Idborg, H., Zhu, L., Li, H., Rao, H., Chen, Z., Guo, Z., Hu, L., Xu, C., et al. (2023) · British Journal of Pharmacology · doi:10.1111/bph.16061 · Cited by 11
da Costa, H. H. M., Orts, D. J. B., Moura, A. D., Duarte‐Neto, A. N., Cirqueira, C. D. S., Réssio, R. A., Kanamura, C. T., Miguita, K., Ferreira, J. E., Santos, R. T. D. M., et al. (2023) · Viruses · doi:10.3390/v15020555 · Cited by 13
Smooth muscle Rac1 contributes to pulmonary hypertension
Dilasser, F., Rio, M., Rose, L., Tesse, A., Guignabert, C., Loirand, G., & Sauzeau, V. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15805 · Cited by 11
Navigating the Seas of Publications in A Medical Journal: The Role of an Editor
Tanwar, S. (2024) · Cureus · doi:10.7759/cureus.55233 · Cited by 11
Carotenuto, L., Keminer, O., Carleo, G., Zaliani, A., Leo, A., Citraro, R., De Sarro, G., Dirkx, N., Kaji, M., Weckhuysen, S., et al. (2025) · British Journal of Pharmacology · doi:10.1111/bph.70119 · Cited by 10
Wang, M., Chen, J., Zhang, Z., Wang, T., Zhao, J., Wang, X., Wang, J., & Zhuang, H. (2025) · Nutrients · doi:10.3390/nu17172800 · Cited by 10
Wu, S., Zhu, Y., Sun, J., Wang, C.-Y., Wang, Y., Nie, Y.-Y., Song, F., Huang, X., Chen, Z., He, T., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-65945-z · Cited by 15
Genuine replication and pseudoreplication
Lazic, S. E. (2022) · Nature Reviews Methods Primers · doi:10.1038/s43586-022-00114-w · Cited by 10
Self-citationSankaran, D., Giusto, E. M., Lesneski, A. L., Hardie, M. E., Joudi, H. M., Lane, E. C. A., Hammitt, V. L., Tully, K. C., Vali, P., & Lakshminrusimha, S. (2023) · Children · doi:10.3390/children10030575 · Cited by 10
Lien, C., Lin, C., Shyue, S., Hsieh, P., Chen, S., Lin, Y., Chien, S., & Tsai, M. (2023) · British Journal of Pharmacology · doi:10.1111/bph.16074 · Cited by 10
Goncalves, S. V., Hathway, G. J., Woodhams, S. G., Chapman, V., & Bast, T. (2023) · Journal of Pain · doi:10.1016/j.jpain.2023.04.002 · Cited by 14
Wang, Q., Liu, T., Chang, H., Li, Z., Chen, L., Mi, X., Xing, H.-Y., Wang, X., Hong, J., Liu, K., et al. (2023) · Brain Sciences · doi:10.3390/brainsci13040657 · Cited by 11
Optogenetic stimulation of the superior colliculus suppresses genetic absence seizures
Campos-Rodríguez, C., Palmer, D. D., & Forcelli, P. A. (2023) · Brain · doi:10.1093/brain/awad166 · Cited by 10
Liu, W., Li, X., Li, N., Mi, Z., Li, N., & Che, J. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1195525 · Cited by 10
Upregulation of circ0000381 attenuates microglial/macrophage pyroptosis after spinal cord injury
Zhang, Y., Zhang, W., Liu, T., Ma, Z., Zhang, W., Guan, Y., & Chen, X. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.386399 · Cited by 10
van Helsdingen, C. P. M., Wildeboer, A. C. L., Zafeiropoulou, K., Jongen, A. C. H. M., Bosmans, J. W. A. M., Gallé, C., Hakvoort, T. B. M., Gijbels, M. J., de Jonge, W. J., Bouvy, N. D., et al. (2023) · BJS Open · doi:10.1093/bjsopen/zrad099 · Cited by 13
Chang, C., Peng, W.-Y., Lee, W.-H., Yang, L., Lin, T., Yang, M., & Tsai, T. (2023) · Communications Medicine · doi:10.1038/s43856-023-00383-w · Cited by 10
Wildner, F., Neuhäusel, T. S., Klemz, A., Kovács, R., Ulmann, L., Geiger, J. R. P., & Gerevich, Z. (2023) · British Journal of Pharmacology · doi:10.1111/bph.16298 · Cited by 11
Adam, M., Özcan, S., Dalkılıç, S., Tektemur, N. K., Tekin, S., Bılgın, B., Hekım, M. G., Bulut, F., Keleştemur, M. M., Canpolat, S., et al. (2023) · Neurotoxicity Research · doi:10.1007/s12640-023-00678-9 · Cited by 12
Romero‐Miguel, D., Casquero‐Veiga, M., Lamanna‐Rama, N., Torres-Sánchez, S., MacDowell, K. S., Garcia-Partida, J. A., Santa-Marta, C., Berrocoso, E., Leza, J. C., Desco, M., et al. (2024) · Translational Psychiatry · doi:10.1038/s41398-023-02652-7 · Cited by 14
Cardioaortic dimensions in German landrace pigs derived from cardiac magnetic resonance imaging
Meissner, F., Galbas, M. C., Szvetics, S., Mühlen, C. V. Z., Heidt, T., Maier, A., Bock, M., Czerny, M., Bothe, W., & Reiss, S. (2024) · Scientific Reports · doi:10.1038/s41598-024-52376-x · Cited by 10
Olivero, G., Taddeucci, A., Vallarino, G., Trebesova, H., Roggeri, A., Gagliani, M. C., Cortese, K., Grilli, M., & Pittaluga, A. (2024) · British Journal of Pharmacology · doi:10.1111/bph.16328 · Cited by 10
Santamarina, A. B., Sertorio, M. N., Mennitti, L. V., de Souza, E. A., de Souza, D. V., Ribeiro, D. A., & Pisani, L. P. (2024) · Journal of Nutrition · doi:10.1016/j.tjnut.2024.03.007 · Cited by 11
Xu, X., Xuan, S., Chen, S., Liu, D., Xiao, Q., & Tu, J. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01411 · Cited by 11
Zimmermann, R., Roeder, F., Ruppert, C., Smith, B. J., & Knudsen, L. (2024) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00323.2023 · Cited by 10
Costa, K. L. D., de Abreu, L. H. F., Tolomei, C. B. D. S., Eleutério, R. G., Basting, R. T., Balbinot, G. D. S., Collares, F. M., Lopes, P. C., Veiga, N., Fernandes, G. V. O., et al. (2024) · Journal of Functional Biomaterials · doi:10.3390/jfb15050124 · Cited by 11
Arcas, J. M., Oudaha, K., González, A., Fernández‐Trillo, J., Peralta, F. A., Castro‐Marsal, J., Poyraz, S., Taberner, F. J., Sala, S., de la Peña, E., et al. (2024) · British Journal of Pharmacology · doi:10.1111/bph.16402 · Cited by 10
Cognitive comorbidities in the rat pilocarpine model of epilepsy
Guarino, A., Pignata, P., Lovisari, F., Asth, L., Simonato, M., & Soukupovà, M. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1392977 · Cited by 10
Circadian time‐dependent effects of experimental colitis on theophylline disposition and toxicity
Yang, Y., Wu, P., Guo, J., Pan, Z., Lin, S., Zeng, W., Wang, C., Dong, Z., & Wang, S. (2024) · British Journal of Pharmacology · doi:10.1111/bph.16440 · Cited by 10
Smith, T. A., Zhou, L., Ghergherehchi, C. L., Mikesh, M., Yang, C. Z., Tucker, H. O., Allgood, J. E., Bushman, J. S., & Bittner, G. D. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01220 · Cited by 12
Contribution of ferroptosis and SLC7A11 to light-induced photoreceptor degeneration
Huang, X., Zhang, Y., Jiang, Y., Li, T., Yang, S., Wang, Y., Yu, B., Zhou, M., Zhang, G., Zhao, X., et al. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01741 · Cited by 12
Sun, H., Yang, T., Simon, R. P., Xiong, Z., & Leng, T. (2024) · Stroke · doi:10.1161/strokeaha.124.047803 · Cited by 12
Panwar, P., Andrault, P.-M., Saha, D., & Brömme, D. (2024) · British Journal of Pharmacology · doi:10.1111/bph.17312 · Cited by 10
Interdisciplinary Animal Research Ethics—Challenges, Opportunities, and Perspectives
Mertz, M., Hetzel, T., Alex, K., Braun, K., Camenzind, S., Dodaro, R., Jörgensen, S., Linder, E., Capas-Peneda, S., Reihs, E. I., et al. (2024) · Animals · doi:10.3390/ani14192896 · Cited by 14
Pericyte ablation causes hypoactivity and reactive gliosis in adult mice
Cashion, J. M., Brown, L. S., Morris, G. P., Fortune, A. J., Courtney, J., Makowiecki, K., Premilovac, D., Cullen, C. L., Young, K. M., & Sutherland, B. A. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.10.014 · Cited by 12
Central amygdala‐to‐pre‐Bötzinger complex neurotransmission is direct and inhibitory
Gu, J., Sugimura, Y. K., Kato, F., & Negro, C. A. D. (2024) · European Journal of Neuroscience · doi:10.1111/ejn.16589 · Cited by 14
Optical control of cardiac electrophysiology by the photochromic ligand azobupivacaine 2
Fehrentz, T., Amin, E., Görldt, N., Strasdeit, T., Moussavi‐Torshizi, S., Leippe, P., Trauner, D. H., Meyer, C., Frey, N., Sasse, P., et al. (2024) · British Journal of Pharmacology · doi:10.1111/bph.17394 · Cited by 10
Du, L., Qin, Q.-G., He, X., Wang, X., Sun, G., Zhu, B., Liu, K., & Gao, X. (2024) · Neurogastroenterology & Motility · doi:10.1111/nmo.14973 · Cited by 10
Salama, R. M., Yehia, R., Elmongy, N. F., Sallam, A. A., Abdel-Galil, M., Schaalan, M. F., Abdel-Mottaleb, M. M. A., & Bazan, L. S. (2024) · Archiv der Pharmazie · doi:10.1002/ardp.202400641 · Cited by 10
Selective PET imaging of CXCR4 using the Al18F-labeled antagonist LY2510924
Spahn, M. A., Loy, T. V., Celen, S., Koole, M. J. B., Deroose, C. M., Cawthorne, C., Vanduffel, W., Schols, D., Bormans, G. M., & Cleeren, F. (2024) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-024-07025-w · Cited by 10
Stark, M., Wang, A. Y., Corrigan, B., Woldu, H. G., Azizighannad, S., Cipolla, G., Kocharian, R., & León, H. D. (2024) · Research and Practice in Thrombosis and Haemostasis · doi:10.1016/j.rpth.2024.102668 · Cited by 10
Vilahur, G., Ben‐Aicha, S., Gutiérrez, M., Aržanauskaitė, M., Mendieta, G., Ramos-Regalado, L., Alcover, S., Casaní, L., Arderiu, G., Padró, T., et al. (2025) · Cardiovascular Research · doi:10.1093/cvr/cvae264 · Cited by 10
Carbone, C., Luca, R. D., Puca, E., Agostini, A., Caggiano, A., Priori, L., Esposito, A., Ascrizzi, S., Piro, G., Salvatore, L., et al. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-03238-x · Cited by 12
Carbonic anhydrase IX inhibition as a path to treat neuroblastoma
Petrošiūtė, A., Zakšauskas, A., Lučiūnaitė, A., Petrauskas, V., Baranauskienė, L., Kvietkauskaitė, A., Ščerbavičienė, A., Tamošiūnaitė, M., Musvicaitė, J., Jankūnaitė, A., et al. (2025) · British Journal of Pharmacology · doi:10.1111/bph.17429 · Cited by 10
Wang, Z., Zhang, L., Wu, T., Xu, P., Li, L., Yang, X., Zhang, M., Liu, Y., & Liu, Y. (2025) · British Journal of Pharmacology · doi:10.1111/bph.17378 · Cited by 10
Novel Soluble Epoxide Hydrolase Inhibitor: Toward Regulatory Preclinical Studies
Jarné‐Ferrer, J., Sánchez, J., Codony, S., Schneider, M., Müller, C. E., Sanfeliu, C., Franco, R., Vázquez, S., Griñán‐Ferré, C., & Pallàs, M. (2025) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.4c00629 · Cited by 12
Öğütveren, M. M., Şatıroğlu, Ö., Özden, Z., Akyıldız, K., Yılmaz, A., Mercantepe, F., Yilmaz, A. S., Koç, H., & Mercantepe, T. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14041315 · Cited by 10
Santamarina, A. B., Moreira, R. G., Mennitti, L. V., Ferreira, Y. A. M., Jucá, A., Prado, C. M., & Pisani, L. P. (2025) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2025.103932 · Cited by 10
Seynhaeve, A. L. B., Liu, H., Priester, M. I., Valentijn, M., van Holten-Neelen, C., Brouwer, R. W. W., van Brakel, M., Dik, W. A., van IJcken, W. F. J., Debets, R., et al. (2025) · Cancer Research · doi:10.1158/0008-5472.can-24-3833 · Cited by 10
Persistent Renal Hypoxia and Histologic Changes at 4 Weeks after Cardiopulmonary Bypass in Sheep
Furukawa, T., May, C. N., Jufar, A. H., Evans, R. G., Cochrane, A. D., Marino, B., McCall, P., Birchall, I. E., Hood, S. G., Raman, J., et al. (2025) · Anesthesiology · doi:10.1097/aln.0000000000005452 · Cited by 10
Koopman, J. E., de Groot, L. G., Zuidam, J. M., Duraku, L. S., Hooijmans, C. R., & Hundepool, C. A. (2025) · Journal of Plastic Reconstructive & Aesthetic Surgery · doi:10.1016/j.bjps.2025.03.048 · Cited by 11
Liao, Y., Zhang, Q., Shi, Q., Liu, P., Zhong, P., Guo, L., Huang, Z., Peng, Y., Liu, W., Zhang, S., et al. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00044 · Cited by 12
Jiang, M., Ding, Z., Huang, Y., Jiang, T., Xia, Y., Gu, D., Gu, X., Bai, H., & Yao, D. (2025) · Biomedicines · doi:10.3390/biomedicines13040872 · Cited by 10
Achasova, K. M., Snytnikova, O. A., Chanushkina, K. E., Morozova, M. V., Tsentalovich, Y. P., & Kozhevnikova, E. N. (2025) · Scientific Reports · doi:10.1038/s41598-025-96514-5 · Cited by 10
Zhao, J., Sun, Y., Liswaniso, S., Wu, H., Sun, X. K., Yan, C., Qin, N., & Xu, R. (2025) · Genes · doi:10.3390/genes16050500 · Cited by 10
Shi, L., Zhu, T., Ge, C., Yang, Y., Wan, Q., & Li, S. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-01474 · Cited by 10
Hu, M., Yi, H., Wang, S., Kang, X., Liu, Y., Liu, Z., Huang, H., Qin, Q., Yuan, L., Cai, W., et al. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-01273 · Cited by 10
Zhou, F., Xia, J., Liu, Y., He, W., Zhang, H., Keavney, B. D., Zi, M., Nguyen, B. Y., Mohamed, T., Miller, J. M., et al. (2025) · British Journal of Pharmacology · doi:10.1111/bph.70094 · Cited by 10
Zhai, L., Zheng, Y., Lo, C. W., Xu, S., Jiang, X., Liu, Q., Ching, J. Y., Ning, Z., Bao, G., Yang, W., et al. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157040 · Cited by 9
Pavanelli, A. L. R., Vieira, S. M., Marcantonio, C. C., Faria, G., Tetradis, S., de Souza, P. P. C., Cirelli, J. A., & de Molon, R. S. (2025) · Journal of Periodontology · doi:10.1002/jper.24-0618 · Cited by 11
Lingappan, K., Sundar, I. K., Prakash, Y. S., Redente, E. F., Sin, D. D., Han, M. K., Lahm, T., Krymskaya, V. P., Kotton, D. N., Kulkarni, H. S., et al. (2025) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202506-1361st · Cited by 14
Karhunen, P. J., Pessi, T., Hörkkö, S., Karhunen, V., Goebeler, S., Louhelainen, A., Martiskainen, M., Haapaniemi, T., Lappeteläinen, J., Ijäs, T., et al. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.125.041521 · Cited by 12
Ma, C., Han, L., Yao, H., Zhao, W., Chen, F., Wu, X., Li, G., Huang, R., Pang, C. H., Zhu, Z., et al. (2025) · British Journal of Pharmacology · doi:10.1111/bph.70160 · Cited by 10
Imber, J., Roccuzzo, A., Monje, A., Pippenger, B. E., Bosshardt, D. D., Sculean, A., & Buser, D. (2025) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.70027 · Cited by 10
Combined Adaptive Immune Mechanisms Mediate Cardiac Injury After COVID-19 Vaccination
Fanti, S., Dyer, C., Ingimarsdóttir, I. J., Harding, D., Wang, G., d’Amati, A., Shahaj, E., Sigurbergsdóttir, A. Ý., Thórsdóttir, H. S., Gunnarsdóttir, O. B., et al. (2025) · Circulation · doi:10.1161/circulationaha.125.074644 · Cited by 12
Tekgüç, M., Matsumoto, T., Altenburger, L. M., Kobayashi, K., Hiratsuka, K., Higashi, Y., Rizki-Safitri, A., Miyoshi, T., El-Jouni, W., Arnaout, M. A., et al. (2026) · npj Biomedical Innovations. · doi:10.1038/s44385-025-00063-5 · Cited by 12
Zelada, D., Barrantes, F. J., & Henríquez, J. P. (2021) · Scientific Reports · doi:10.1038/s41598-021-96708-7 · Cited by 10
Targeting the BMP Pathway in Prostate Cancer Induced Bone Disease
Straign, D. M., Ihle, C. L., Provera, M. D., & Owens, P. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.769316 · Cited by 10
Antiorio, A. T. F. B., Alemán-Laporte, J., de Freitas, A. P. P., Yamamoto, P. K., Cintra, L., & Mori, C. M. C. (2022) · Veterinary Research Communications · doi:10.1007/s11259-021-09868-2 · Cited by 10
Lee, K., Shin, S., Hämmerle, C. H. F., Jung, U., Lim, H., & Thoma, D. S. (2022) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.13594 · Cited by 10
A high-fat diet has negative effects on tendon resident cells in an in vivo rat model
Bolam, S. M., Konar, S., Park, Y. E., Callon, K. E., Workman, J., Monk, A. P., Coleman, B., Cornish, J., Vickers, M. H., Munro, J. T., et al. (2022) · International Orthopaedics · doi:10.1007/s00264-022-05340-1 · Cited by 10
Moreno, M., Minjarez, C., Vigil, J. J., Orfila, J. E., Schmidt, R., Burch, A. M., Carter, D. J., Kubesh, M., Yonchek, J. C., Dietz, R. M., et al. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105701 · Cited by 10
Kwon, K. W., Kim, L., Kang, S. M., Lee, J. M., Choi, E., Park, J., Hong, J. J., & Shin, S. J. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15838 · Cited by 13
Wang, X., Wang, T., Jin, J., Wang, H., Li, Y., Liu, Z., & Yin, T. (2022) · BMC Anesthesiology · doi:10.1186/s12871-022-01655-z · Cited by 11
Dog as the experimental model: Laboratory uses of dogs in the United States
Ward, S. L. (2022) · ALTEX · doi:10.14573/altex.2109101 · Cited by 11
Addis, M. F., Maffioli, E., Penati, M., Albertini, M., Bronzo, V., Piccinini, R., Tangorra, F. M., Tedeschi, G., Cappelli, G., Vuolo, G. D., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-12297-z · Cited by 10
Metadata
- Authors
- Percie du Sert, N., Hurst, V., Ahluwalia, A., Alam, S., Avey, M. T., Baker, M., Browne, W. J., Clark, A., Cuthill, I. C., Dirnagl, U., Emerson, M., Garner, P., Holgate, S. T., Howells, D. W., Karp, N. A., Lazic, S. E., Lidster, K., MacCallum, C. J., Macleod, M., Pearl, E. J., Petersen, O. H., Rawle, F., Reynolds, P., Rooney, K., Sena, E. S., Silberberg, S. D., Steckler, T., & Würbel, H.
- Affiliations
- National Centre for the Replacement Refinement and Reduction of Animals in Research (GB)
- Queen Mary University of London (GB)
- Taylor and Francis (United Kingdom)
- University of Bristol (GB)
- Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE)
- Imperial College London (GB)
- Liverpool School of Tropical Medicine (GB)
- University of Southampton (GB)
- University of Tasmania (AU)
- AstraZeneca (United Kingdom) (GB)
- Prioris.ai (Canada) (CA)
- Hindawi (United Kingdom) (GB)
- University of Edinburgh (GB)
- Cardiff University (GB)
- Medical Research Council (GB)
- University of Florida (US)
- The University of Sydney (AU)
- National Institute of Neurological Disorders and Stroke (US)
- Janssen (Belgium) (BE)
- University of Bern (CH)
- ORCID
- Percie du Sert, Nathalie
- Hurst, Viki
- Ahluwalia, Amrita
- Alam, Sabina
- Avey, Marc T.
- Browne, William J.
- Clark, Alejandra
- Cuthill, Innes C.
- Dirnagl, Ulrich
- Emerson, Michael
- Garner, Paul
- Holgate, Stephen T.
- Howells, David W.
- Karp, Natasha A.
- Lazic, Stanley E.
- MacCallum, Catriona J.
- Macleod, Malcolm
- Pearl, Esther J.
- Petersen, Ole H.
- Rawle, Frances
- Reynolds, Penny
- Rooney, Kieron
- Sena, Emily S.
- Silberberg, Shai D.
- Steckler, Thomas
- Würbel, Hanno
- Venue
- PLOS Biology
- Publisher
- Public Library of Science (PLoS)
- Published
- 2020-07-14
- Volume
- 18
- Issue
- 7
- Pages
- e3000410
- ISSN
- 1544-9173 (ISSN-L)
- 1545-7885
- PMC
- PMC7360023
- OpenAlex
- W4236357753
- Cited by
- 5,939
- References
- 60
- Citations by year
- 2026: 1201 · 2025: 1307 · 2024: 994 · 2023: 920 · 2022: 823 · 2021: 579 · 2020: 106
- FWCI
- 520.24
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- public-domain
- creativecommons.org/publicdomain/zero/1.0/ (vor)
- Locations
- PLoS Biology (publishedVersion, public-domain)
- PubMed (publishedVersion)
- PubMed Central (submittedVersion, public-domain)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by)
- Bristol Research (University of Bristol) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion, other-oa)
- Funders
- National Centre for the Replacement, Refinement and Reduction of Animals in Research
- Topics
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
- Social Sciences › Library and Information Sciences › Academic Writing and Publishing
- Keywords
- ARRIVE guidelines, animal research reporting, in vivo experiments, research transparency, reproducibility, reporting checklist, methodological quality, peer review, journal editorial policy
- MeSH terms
- Animals, Guidelines as Topic, Animal Experimentation, Checklist, Research Report
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-24, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-24 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.